Baldwin Brothers LLC Novartis Ag Transaction History

Baldwin Brothers LLC

$1.45 Billion
Q3 2025

A detailed history of Baldwin Brothers LLC transactions in Novartis Ag stock. As of the latest transaction made, Baldwin Brothers LLC holds 33,850 shares of NVS stock, worth $4.4 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

33,850

Previous 37,644 10.08%

Holding current value

$4.4 Million

Previous $4.56 Million 4.72%

% of portfolio

0.3%

Previous 0.33%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	SELL	$113.5 - $129.73 $430,619 - $492,195	-3,794 Reduced 10.08%	33,850 $4.34 Million
Q2 2025 Jul 24, 2025	SELL	$101.96 - $121.01 $385,000 - $456,933	-3,776 Reduced 9.12%	37,644 $4.56 Million
Q1 2025 Apr 14, 2025	SELL	$97.14 - $115.57 $666,186 - $792,579	-6,858 Reduced 14.21%	41,420 $4.62 Million
Q4 2024 Jan 22, 2025	SELL	$96.78 - $117.18 $631,683 - $764,833	-6,527 Reduced 11.91%	48,278 $4.7 Million
Q3 2024 Oct 15, 2024	BUY	$106.13 - $120.89 $769,124 - $876,089	7,247 Added 15.24%	54,805 $6.3 Million
Q2 2024 Jul 12, 2024	SELL	$92.57 - $107.37 $140,336 - $162,772	-1,516 Reduced 3.09%	47,558 $5.06 Million
Q1 2024 Apr 12, 2024	SELL	$95.27 - $108.47 $136,521 - $155,437	-1,433 Reduced 2.84%	49,074 $4.75 Million
Q4 2023 Jan 08, 2024	SELL	$92.27 - $101.54 $182,879 - $201,252	-1,982 Reduced 3.78%	50,507 $5.1 Million
Q3 2023 Oct 10, 2023	BUY	$94.73 - $105.13 $31,545 - $35,008	333 Added 0.64%	52,489 $5.35 Million
Q2 2023 Jul 14, 2023	SELL	$92.52 - $104.91 $53,569 - $60,742	-579 Reduced 1.1%	52,156 $5.26 Million
Q1 2023 Apr 21, 2023	BUY	$80.03 - $92.81 $18,166 - $21,067	227 Added 0.43%	52,735 $4.85 Million
Q4 2022 Jan 27, 2023	BUY	$75.55 - $92.52 $3.85 Million - $4.71 Million	50,894 Added 3153.28%	52,508 $0
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $3,623 - $4,218	-45 Reduced 2.71%	1,614 $136,000
Q1 2022 Apr 13, 2022	SELL	$80.11 - $90.62 $2,403 - $2,718	-30 Reduced 1.78%	1,659 $146,000
Q4 2021 Jan 14, 2022	SELL	$79.7 - $88.13 $39,531 - $43,712	-496 Reduced 22.7%	1,689 $148,000
Q3 2021 Oct 27, 2021	BUY	$81.78 - $95.14 $6,215 - $7,230	76 Added 3.6%	2,185 $179,000
Q2 2021 Jul 30, 2021	SELL	$85.24 - $94.15 $5,966 - $6,590	-70 Reduced 3.21%	2,109 $192,000
Q1 2021 Apr 08, 2021	BUY	$83.5 - $98.47 $18,119 - $21,367	217 Added 11.06%	2,179 $186,000
Q3 2020 Oct 16, 2020	BUY	$82.14 - $91.0 $5,339 - $5,915	65 Added 3.43%	1,962 $171,000
Q1 2020 Apr 15, 2020	BUY	$70.67 - $99.01 $3,392 - $4,752	48 Added 2.6%	1,897 $156,000
Q4 2019 Jan 29, 2020	BUY	$84.35 - $95.37 $2,699 - $3,051	32 Added 1.76%	1,849 $175,000
Q3 2019 Oct 10, 2019	BUY	$85.54 - $94.26 $136,436 - $150,344	1,595 Added 718.47%	1,817 $158,000
Q3 2018 Oct 26, 2018	BUY	$66.94 - $77.43 $1,472 - $1,703	22 Added 11.0%	222 $19,000
Q1 2018 Apr 16, 2018	BUY	$70.39 - $84.15 $14,078 - $16,830	200 New	200 $16,000
Q4 2017 Jan 24, 2018	SELL	$72.33 - $77.64 $14,466 - $15,528	-200 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$74.14 - $77.27 $14,828 - $15,454	200	200 $17,000

Others Institutions Holding NVS

# of Institutions

1,560

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $280B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Novartis Ag Transaction History